Beta: Sign in
Shares outstandingAs of 2026-08-03 · filed common shares: 55.93M
Shares float: Sign in
Float %: Sign in
Insider ownershipDirectors and officers, from their latest Form 3/4/5 holding: 0.48%
Institutional ownership: Sign in
Short interestShare of shares outstanding, at settlement: 15.07%
Short ratioDays to cover, as published by FINRA: 15.31
Short volume (5D)Share of FINRA reporting-facility volume sold short, daily flow: 43.70%
Short volume (20D)Share of FINRA reporting-facility volume sold short, daily flow: 51.50%
Avg volume (10D)

See the full stock page

Prices, charts, ranges, valuation ratios, dividends, momentum and analyst estimates are licensed for signed-in members. A free account opens every stock, fund and crypto page.

Create free account

Source: SEC filings. Information and analytics, not investment advice.

Rev growth (fwd)

Avg volume (3 months)

Profitability

Gross margin: —
Operating marginFY Dec 25: -8739.34%
Net margin: —
EBITDA marginFY Dec 25: -8733.89%
Return on equityNet income (TTM to Jun 26) ÷ average shareholders equity: -26.07%
Return on assetsNet income (TTM to Jun 26) ÷ average total assets: -24.98%

Growth

Revenue growth (annual YoY): -67.35%
Revenue growth (latest qtr YoY): -81.77%
Revenue growth (fwd): Sign in
Net income growth (annual YoY): —
Net income growth (latest qtr YoY): —
EPS growth (fwd): Sign in
Net income growth (QoQ): —

Valuation

Market cap: Sign in
Enterprise value: Sign in
P/E: Sign in
P/E (fwd): Sign in
PEG: Sign in
PEG (fwd): Sign in
Price / book: Sign in
Price / sales

Price / operating cash flow

P/FCF

EV / revenue

EV / EBITDA

EPSDiluted, TTM to Mar 26

-4.23

EPS (fwd)

Financial health

Cash & equivalentsas of Jun 26: $110.54M
Total cash: Sign in
Total debtBorrowings + finance and operating lease liabilities, as of Jun 26: $1.28M
Debt / equityas of Jun 26: 0.11%
Current ratioas of Jun 26: 26.10
Quick ratio(Cash + marketable securities + receivables) ÷ current liabilities, as of Jun 26: 25.79
Operating cash flowTTM to Jun 26: -$155.37M
Free cash flowUnadjusted FCF = CFO − capex · TTM to Jun 26: -$155.37M
TTM revenue / diluted share: —

DNTH stock Statistics — Dianthus Therapeutics, Inc. /DE/ filings, insiders & smart money · Instaport